Abstract. Fucoxanthin is a major carotenoid found in edible seaweed such as Undaria pinnatifida and Hijikia fusiformis. We investigated the suppressive effects of fucoxanthin and its metabolite, fucoxanthinol, on the differentiation of 3T3-L1 preadipocytes to adipocytes. Fucoxanthin inhibited intercellular lipid accumulation during adipocyte differentiation of 3T3-L1 cells. Furthermore, fucoxanthin was converted to fucoxanthinol in 3T3-L1 cells. Fucoxanthinol also exhibited suppressive effects on lipid accumulation and decreased glycerol-3-phosphate dehydrogenase activity, an indicator of adipocyte differentiation. The suppressive effect of fucoxanthinol was stronger than that of fucoxanthin. In addition, in 3T3-L1 cells treated with fucoxanthin and fucoxanthinol, peroxisome proliferator-activated receptor Á (PPARÁ), which regulates adipogenic gene expression, was down-regulated in a dosedependent manner. These results suggest that fucoxanthin and fucoxanthinol inhibit the adipocyte differentiation of 3T3-L1 cells through down-regulation of PPARÁ. Fucoxanthinol had stronger suppressive effects than fucoxanthin on adipocyte differentiation in 3T3-L1 cells.
Introduction
Adipocytes have an important role in energy homeostasis. Adipose tissue stores energy in the form of lipid and releases fatty acids in response to nutritional signals or energy insufficiency (1) . Further, adipocytes have endocrine functions by secreting hormones and factors that regulate physiological functions, such as immune response, insulin sensitivity and food intake (2, 3) . Excessive fat accumulation in the body and white adipose tissue causes obesity and results in an increased risk of many serious diseases, including type II diabetes, hypertension and heart disease. The regulation of adipose differentiation has been studied for the prevention of life stylerelated diseases (4, 5) because adipose tissue development is closely related to adipocyte differentiation.
Carotenoids have beneficial health effects such as provitamin A activity, immune response modulation, and anticarcinogenic activity (6) . Fucoxanthin ( Fig. 1 ), which has a unique structure including an allenic bond and a 5,6-monoepoxide in the molecule (7), is a major marine carotenoid found in edible seaweeds such as Undaria pinnatifida, Hijikia fusiformis and Sargassum fulvellum. In Southeast Asian countries, some seaweeds containing fucoxanthin are often used as a food source. Fucoxanthin has anti-carcinogenic effects (8, 9) , apoptotic effects in cancer cells (10-13), antiinflammatory effects (14) , and radical scavenging activity (15) . We recently reported that dietary fucoxanthin suppressed weight gain of white adipose tissue in an obese mouse model, KK-Ay (16) . Because most body fat is stored in white adipose tissue, decreasing white adipose tissue weight by fucoxanthin might be a very effective approach for preventing and/or alleviating obesity. The effects of fucoxanthin and its metabolite on the cellular mechanisms responsible for adipocyte differentiation, however, are unknown.
In the present study, we investigated the effects of fucoxanthin and its metabolite, fucoxanthinol (Fig. 1) , on the differentiation of a murine 3T3-L1 preadipocyte cell line. In addition, the incorporation and metabolism of fucoxanthin in 3T3-L1 cells were analyzed. Fucoxanthin suppressed intracellular lipid accumulation and glycerol-3-phosphate dehydrogenase (GPDH) activity induced during adipose differentiation in 3T3-L1 cells. Some of the fucoxanthin incorporated into 3T3-L1 cells was converted to the metabolite, fucoxanthinol. Fucoxanthinol suppressed 3T3-L1 cell differentiation, accompanied by a down-regulation of peroxisome proliferator-activated receptor Á (PPARÁ). Fucoxanthinol had greater suppressive effects on 3T3-L1 cell differentiation than fucoxanthin. 3T3-L1 culture. 3T3-L1 cells were cultured in DMEM with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin at 37˚C in a humidified atmosphere of 95% air and 5% CO 2 . After 3T3-L1 cells reached confluence, they were incubated for an additional 24 h. Then, adipocyte differentiation of 3T3-L1 preadipocytes was initiated using differentiation medium I containing 10 μg/ml insulin, 0.5 mM isobutylmethylxanthine and 0.1 μM dexamethazone for 48 h. The medium was then replaced with DMEM containing 5 μg/ml insulin (differentiation medium II), and changed to fresh medium every 2 days. Fucoxanthin and fucoxanthinol were added to differentiation medium II as ethanol solution. The final concentration of ethanol was adjusted to 0.1% so as not to affect cell growth. The cytotoxicity of fucoxanthin and fucoxanthinol on 3T3-L1 cells was determined using WST-1 assay (17) . HPLC analysis. Fucoxanthin and fucoxanthinol extracted with chloroform:methanol (1:2, v/v) from 3T3-L1 cells were analyzed using a high performance liquid chromatograph (HPLC, Hitachi, Tokyo, Japan) system equipped with a Lichrospher@ RP-18e column (4x250 mm, Merck). The mobile phase used was methanol/acetonitrile (7:3, v/v) at a flow rate of 1.0 ml/min and carotenoids were detected at 450 nm by a diod array detector (L7455 type, Hitachi). The amount of fucoxanthin and fucoxanthinol were quantified from their peak area by use of a standard curve with purified fucoxanthin and fucoxanthinol.
Materials and methods

Materials
Measurement of GPDH activity. Glycerol phosphate dehydrogenase (GPDH, EC 1.1.1.8) activity (19) was measured using a commercial assay kit (Hokudo Co., Ltd., Sapporo, Hokkaido, Japan) according to the manufacturer's instructions. 3T3-L1 cells incubated in differentiation medium II containing carotenoid for 120 h were washed twice with PBS and dissolved in enzyme extract solution. Then, the cell lysate was homogenized by supersonic waves on ice, and centrifuged at 2,800 g for 5 min at 4˚C. The supernatant was used for the measurement of GPDH activity. The protein content was measured with a DC protein assay kit (Bio-Rad Laboratories, Inc., Tokyo, Japan).
Western blot analysis. 3T3-L1 cells were incubated in differentiation medium II containing carotenoid for 120 h. Cells were lysed with cold RIPA buffer (pH 7.4) containing 20 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS), 0.1 mg/ml phenylmethylsulphonyl fluoride, 50 μg/ml aprotinin and 1 mM Na 3 VO 4 . Cell lysates were centrifuged at 13,000 g for 20 min at 4˚C, and supernatant (30 μg protein/lane) was separated by 10% SDS-polyacrylamide gel electrophoresis. Proteins were transferred to polyvinylidene difluoride membrane. The membrane was incubated with an antibody against PPARÁ for 1 h and then with secondary antibody rabbit IgG-conjugated horseradish peroxidase (Santa Cruz Biotechnology) for 1 h at room temperature. The membranes were treated with reagents in the chemiluminescence detection kit (ECL system, Amersham Pharmacia Biotech, Piscataway, NJ, USA) according to the manufacturer's instructions. ß-Actin was used as the control with the anti-ß-Actin antibody.
Statistical analysis. Statistical significance of differences was evaluated by Student's t-test. 
Results
Effect of fucoxanthin on lipid accumulation during adipocyte differentiation.
The effect of fucoxanthin on lipid accumulation during 3T3-L1 differentiation was examined using Oil Red-O dye staining, which indicates intercellular lipid accumulation. Fucoxanthin attenuated the Oil Red-O staining level (Fig. 2) . The Oil Red-O staining level of 3T3-L1 cells treated with 15 μM fucoxanthin for 120 h was reduced to 70% that of differentiated 3T3-L1 adipocytes. We also measured the viability of 3T3-L1 cells treated with fucoxanthin. Fucoxanthin was not cytotoxic to 3T3-L1 cells after 120 h incubation at 15 μM (data not shown).
Uptake and conversion of fucoxanthin in 3T3-L1 cells.
Fucoxanthin added to the culture medium was incorporated into 3T3-L1 cells after 24-h incubation (Fig. 3) . Fucoxanthinol, which is a deacetylated derivative of fucoxanthin, was also detected in the cells (Fig. 3) but not in the culture medium (data not shown). When 10 μM fucoxanthin was added to differentiation media II , the fucoxanthin level in the cells was 1.2 μg/mg protein after 24-h incubation and did not remarkably change until after 57-h incubation. On the other hand, the fucoxanthinol level increased to 4.9 μg/mg protein after 57-h incubation from 0.9 μg/protein after 24-h incubation. We also measured fucoxanthinol uptake by 3T3-L1 cells. Intracellular fucoxanthinol levels reached 5.8 μg/mg protein after 24-h incubation and increased for up to 48 h. The accumulation of fucoxanthinol in 3T3-L1 cells treated with fucoxanthinol was markedly higher than the accumulation of fucoxanthin and fucoxanthinol together in cells treated with fucoxanthin.
Effect of fucoxanthinol on adipocyte differentiation. Because some of the fucoxanthin incorporated into 3T3-L1 cells was converted to fucoxanthinol, we examined the suppressive effects of fucoxanthinol on 3T3-L1 differentiation. Fucoxanthinol attenuated lipid accumulation in 3T3-L1 cells in a dose-dependent manner (Fig. 4) . The Oil-Red O staining level of 3T3-L1 cells treated with 10 μM fucoxanthinol for 120 h decreased to 14% that of control cells, in which adipocyte differentiation was induced without fucoxanthinol.
The effect of fucoxanthinol and fucoxanthin on GPDH activity was also examined as an indicator of 3T3-L1 adipocyte differentiation. In 3T3-L1 cells treated with fucoxanthinol and fucoxanthin, GPDH activity was reduced to a level comparable to that of control cells (Fig. 5) . Specifically, the GPDH activity in 3T3-L1 cells treated with 5 and 7.5 μM fucoxanthinol for 120 h was significantly lower than that in 3T3-L1 cells treated with fucoxanthin (Fig. 5) . On the other hand, no toxicity was observed in cells treated with up to 10 μM fucoxanthinol (data not shown). and is expressed during the early to middle stage of adipocyte differentiation (20) . To investigate the mechanisms underlying fucoxanthin and fucoxanthinol-induced suppression of adipocyte differentiation, the expression of PPARÁ protein in 3T3-L1 cells treated with carotenoids was analyzed by Western blotting. PPARÁ was markedly induced during adipocyte differentiation (Fig. 6) . Fucoxanthinol down-regulated PPARÁ in 3T3L1 cells after 120-h incubation. At 5 μM fucoxanthinol, the PPARÁ expression level decreased to 47% that of control cells differentiated without carotenoid. Fucoxanthin also down-regulated PPARÁ after 120-h incubation.
Protein expression of PPARÁ in 3T3-
Discussion
Fucoxanthin is a carotenoid contained in edible brown seaweeds and is one of the most abundant carotenoids, along with ß-carotene, in nature. Asian people, including Japanese and Koreans, often consume fucoxanthin-rich brown seaweeds such as Undaria pinnatifida and Hijikia fusiformis as a food source. Recently, we demonstrated that fucoxanthin suppressed the weight gain of white adipose tissue in a mouse diabetesobesity model, KK-Ay (16). The incidence of obesity is related with the differentiation of preadipocytes to adipocytes and the enlargement of adipocytes in adipose tissues (21, 22) . Therefore, we investigated the effects of fucoxanthin on the differentiation of 3T3-L1 cells to clarify the anti-obesity mechanism of dietary fucoxanthin. Fucoxanthin significantly suppressed lipid accumulation in 3T3-L1 cells at a concentration that was not cytotoxic. GPDH activity was decreased in 3T3-L1 cells treated with fucoxanthin compared to control cells incubated in the differentiation medium. Because GPDH is important for triacylglycerol synthesis (23) , the present results indicate that fucoxanthin suppresses adipocyte differentiation.
Studies of the uptake and metabolism of fucoxanthin in 3T3-L1 cells indicated that fucoxanthin added to culture medium was incorporated into cells and further converted to fucoxanthinol by deacetylation within 24 h. Fucoxanthinol but not fucoxanthin levels increased in a time-dependent manner. In addition, the carotenoid accumulation in 3T3-L1 cells was greater following treatment with fucoxanthinol than after treatment with fucoxanthin. Sugawara et al (24) and Asai et al (25) also reported that orally administered fucoxanthin is detected as fucoxanthinol and amarouciaxanthin A in the blood and liver. Therefore, we examined the suppressive effects of fucoxanthinol on 3T3-L1 adipocyte differentiation.
Fucoxanthinol markedly suppressed lipid accumulation during adipocyte differentiation in a dose-dependent manner. Fucoxanthinol (5.0 and 7.5 μM) inhibited GPDH activity to a greater extent than fucoxanthin. These results indicate that fucoxanthinol might be the active compound for the antiobesity effect induced in vivo by fucoxanthin administration. It is noteworthy that PPARÁ levels were down-regulated in 3T3-L1 cells treated with fucoxanthinol and fucoxanthin. PPARÁ has an important role in the early stages of 3T3-L1 cell differentiation (26, 27) because it is a nuclear transcription factor that regulates adipogenic gene expression (20) . These results indicate that fucoxanthin and fucoxanthinol suppress the differentiation of preadipocytes to adipocytes in 3T3-L1 cells and their suppressive effect is, at least, one mechanism underlying the anti-obesity effect of dietary fucoxanthin. Some other natural compounds and extracts, including catechin (28), sterols (29) , tannic acid (30), phenolic lipids (31) and red yeast rice extracts (32) , also inhibit 3T3-L1 differentiation. Retinoids also inhibit the early stage of differentiation of 3T3-L1 cells (33) . Some of these compounds and extracts, however, have low absorption and have not been investigated for their anti-obesity effects in vivo. Because fucoxanthin accumulates as metabolites, including fucoxanthinol, in white adipose tissue of mice (data not shown), dietary fucoxanthin might be a useful natural compound for the prevention of obesity. were differentiated to adipocytes as described in Materials and methods. 3T3-L1 cells were treated with fucoxanthin or fucoxanthinol in differentiation medium II for 120 h. Cellular protein was extracted, and PPARÁ protein levels were detected using Western blot analysis and were quantified by densitometry. The PPARÁ protein expression level was normalized to the ß-Actin level and expressed as the value relative to preadipocyte PPARÁ levels.
Uncoupling protein 1 (UCP1) is expressed in the white adipose tissue of mice fed diets including fucoxanthin (16) . UCP1 is a key molecule for metabolic thermogenesis for avoiding excessive fat accumulation (34) , and the expression of UCP1 mRNA is regulated by PPARÁ (35) and ß-adrenergic receptors (36) . The relationship between UCP1 up-regulation and PPARÁ down-regulation, however, is not clear. Fucoxanthin and fucoxanthinol might have multiple suppressive effects on obesity. Further investigation is needed to elucidate the mechanisms underlying fucoxanthin's anti-obesity effects.
In conclusion, fucoxanthin, found in edible brown seaweeds, suppressed the differentiation of 3T3-L1 preadipocytes to adipocytes. Fucoxanthin was incorporated and converted to fucoxanthinol in 3T3-L1 cells. The metabolite, fucoxanthinol, also exhibited suppressive effects on 3T3-L1 differentiation through PPARÁ down-regulation. These findings indicate that diets containing fucoxanthin might prevent obesity through the suppression of adipocyte differentiation.
